Aarti Drugs posts Q2 FY25 consolidated profit at Rs. 35.01 Cr
Aarti Drugs has reported total income of Rs. 599.81 crores during the period ended September 30, 2024
Aarti Drugs has reported total income of Rs. 599.81 crores during the period ended September 30, 2024
Glenmark Pharmaceuticals Limited has informed that the USFDA has issued Form 483 with zero observations
Capital expenditure expected to moderate to Rs. 5.6 billion in FY2025 from an estimated Rs. 7.6 billion in FY2024
The company has posted net profit of Rs.171.42 crores for the Financial Year ended March 31, 2024
Aarti Drugs has reported total income of Rs. 607.61 crores during the period ended December 31, 2023
Aarti Drugs has reported total income of Rs. 642.22 crores during the period ended September 30, 2023
The company has received Export Performance Award - API & Intermediaries Gold Star for the year 2021-22
Specialty Chemicals grew 38% YoY for FY23
Standalone Q3 FY23 revenue stood at Rs. 626.5 crore as against Rs. 594.8 crore, a growth of 5% YoY
Subscribe To Our Newsletter & Stay Updated